Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Change in Receivables (2020 - 2025)

Beauty Health (SKIN) has disclosed Change in Receivables for 6 consecutive years, with -$2.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Receivables rose 12.67% to -$2.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$12.2 million, a 48.77% increase, with the full-year FY2024 number at -$20.8 million, down 25.93% from a year prior.
  • Change in Receivables was -$2.5 million for Q3 2025 at Beauty Health, down from $1.7 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $20.3 million in Q2 2022 to a low of -$10.5 million in Q4 2023.
  • A 5-year average of $1.1 million and a median of -$2.8 million in 2024 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: surged 3776.55% in 2021, then plummeted 198.79% in 2023.
  • Beauty Health's Change in Receivables stood at $13.7 million in 2021, then tumbled by 162.7% to -$8.6 million in 2022, then dropped by 22.17% to -$10.5 million in 2023, then rose by 29.08% to -$7.5 million in 2024, then skyrocketed by 66.63% to -$2.5 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Change in Receivables are -$2.5 million (Q3 2025), $1.7 million (Q2 2025), and -$4.0 million (Q1 2025).